MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - mnc pharma
- ABBOTT INDIA - MYLAN (US)
ABBOTT INDIA vs MYLAN (US) - Comparison Results
ABBOTT INDIA Change
Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More
MYLAN (US)
Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More
Financials
 ABBOTT INDIA  MYLAN |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| ABBOTT INDIA Mar-19 |
MYLAN Dec-18 |
ABBOTT INDIA/ MYLAN |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 8,834 | 3,470 | - | |
| Low | Rs | 5,458 | 1,910 | - | |
| Sales per share (Unadj.) | Rs | 1,731.1 | 1,596.7 | - | |
| Earnings per share (Unadj.) | Rs | 211.9 | 43.4 | - | |
| Cash flow per share (Unadj.) | Rs | 219.9 | 342.3 | - | |
| Dividends per share (Unadj.) | Rs | 65.00 | 0 | - | |
| Dividend yield (eoy) | % | 0.9 | 0 | - | |
| Book value per share (Unadj.) | Rs | 945.2 | 1,727.4 | - | |
| Shares outstanding (eoy) | m | 21.25 | 514.50 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 4.1 | 1.7 | 245.0% | |
| Avg P/E ratio | x | 33.7 | 62.0 | 54.3% | |
| P/CF ratio (eoy) | x | 32.5 | 7.9 | 413.6% | |
| Price / Book Value ratio | x | 7.6 | 1.6 | 485.5% | |
| Dividend payout | % | 30.7 | 0 | - | |
| Avg Mkt Cap | Rs m | 151,848 | 1,384,010 | 11.0% | |
| No. of employees | `000 | 3.5 | 35.0 | 10.0% | |
| Total wages/salary | Rs m | 4,356 | 0 | - | |
| Avg. sales/employee | Rs Th | 10,555.5 | 23,471.7 | 45.0% | |
| Avg. wages/employee | Rs Th | 1,249.9 | 0 | - | |
| Avg. net profit/employee | Rs Th | 1,292.2 | 637.4 | 202.7% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 36,786 | 821,510 | 4.5% | |
| Other income | Rs m | 1,133 | 0 | - | |
| Total revenues | Rs m | 37,919 | 821,510 | 4.6% | |
| Gross profit | Rs m | 6,047 | 212,576 | 2.8% | |
| Depreciation | Rs m | 169 | 153,819 | 0.1% | |
| Interest | Rs m | 23 | 39,512 | 0.1% | |
| Profit before tax | Rs m | 6,989 | 19,246 | 36.3% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 2,485 | -3,062 | -81.2% | |
| Profit after tax | Rs m | 4,503 | 22,307 | 20.2% | |
| Gross profit margin | % | 16.4 | 25.9 | 63.5% | |
| Effective tax rate | % | 35.6 | -15.9 | -223.5% | |
| Net profit margin | % | 12.2 | 2.7 | 450.8% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 27,610 | 458,731 | 6.0% | |
| Current liabilities | Rs m | 8,569 | 334,465 | 2.6% | |
| Net working cap to sales | % | 51.8 | 15.1 | 342.2% | |
| Current ratio | x | 3.2 | 1.4 | 234.9% | |
| Inventory Days | Days | 60 | 84 | 72.0% | |
| Debtors Days | Days | 27 | 93 | 29.4% | |
| Net fixed assets | Rs m | 1,057 | 159,359 | 0.7% | |
| Share capital | Rs m | 213 | 437 | 48.6% | |
| Net worth | Rs m | 20,086 | 888,724 | 2.3% | |
| Long term debt | Rs m | 0 | 959,218 | 0.0% | |
| Total assets | Rs m | 29,409 | 2,383,903 | 1.2% | |
| Interest coverage | x | 311.6 | 1.5 | 20,953.7% | |
| Debt to equity ratio | x | 0 | 1.1 | 0.0% | |
| Sales to assets ratio | x | 1.3 | 0.3 | 363.0% | |
| Return on assets | % | 15.4 | 2.6 | 593.4% | |
| Return on equity | % | 22.4 | 2.5 | 893.2% | |
| Return on capital | % | 34.9 | 3.2 | 1,097.8% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 4,991 | 170,710 | 2.9% | |
| From Investments | Rs m | -2,570 | -88,238 | 2.9% | |
| From Financial Activity | Rs m | -1,428 | -79,527 | 1.8% | |
| Net Cashflow | Rs m | 993 | 1,414 | 70.2% | |
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 72.9 Rs / USD
Compare ABBOTT INDIA With: ADCOCK INGRAM (S. Africa) ACTAVIS (US) TEVA PHARMA (Israel)
Compare ABBOTT INDIA With: NOVARTIS SANOFI INDIA DISHMAN PHARMA LUPIN DR. REDDYS LAB
Today's Market
Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)
Indian share markets witnessed huge selling during closing hours today and ended their day lower.
Related Views On News
ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)
Feb 11, 2021 | Updated on Feb 11, 2021For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)
Aug 18, 2020 | Updated on Aug 18, 2020For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
More Views on NewsMost Popular
It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)
Feb 24, 2021Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)
Feb 25, 2021In this video, I'll show you how to get started on the path to daily trading profits.
The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)
Feb 23, 2021An Indian company founded three decades ago in a garage caught my attention...
How Much Money For Day Trading? (Fast Profits Daily)
Feb 22, 2021In this video, I'll show you how to allocate your capital as a day trader.
More
